ETS-EUSAAT joint afternoon symposium
Innovations and applications of the embryonic stem cell test (EST)
Wednesday, September 5th, 2012 - 14:00-18:00
Programme |
|
Chairs: Aldert Piersma (ETS), Horst Spielmann (EUSAAT) | |
14:00-14:30 | Horst Spielmann*, FU Berlin, DE Historic perspective of the EST (embryonic stem cell test) assay |
14:30-15:00 | Aldert Piersma*, RIVM, NL Embryonic Stem Cell approaches towards biomarkers of embryotoxicity |
15:00-15:30 | Peter Theunissen*, Aldert Piersma, RIVM, NL Development of the neural embryonic stem cell test (ESTn): a model for screening (neuro)developmental toxicity |
15:30-16:00 | Christian Riebeling, Andreas Luch, Andrea Seiler*, BfR, DE The validated embryonic stem cell test (EST) and its applicability domain |
16:00-16:30 | Coffee break |
16:30-17:00 | Agapios Sachinidis*, University Cologne, DE Identification of thalidomide-specific transcriptomic and proteomics signatures during differentiation of human embryonic stem cells |
17:00-17:30 | Tom Knudsen*, EPA, US Simulating developmental toxicity in a virtual embryo |
17:30-18:00 | Claudia McGinnis*, Roche Basel, CH High Throughput Design in industry: Novel automation approaches for improved predictivity in early safety assessment |
18:00 | Closing remarks |
* lecturer | |